The event will focus on the management of adult patients with locally advanced or metastatic urothelial carcinoma who are progression-free following platinum-based chemotherapy; and adult patients with advanced renal cell carcinoma. Our expert faculty will discuss the latest data presented at ASCO® Genitourinary (GU) Cancers Symposium 2023 and the impact on clinical practice in the UK. They will also discuss and debate the latest hot topics in the field; providing practical advice and guidance on treating these patients through patient case studies and real-world experience.
Merck is a global science and technology company with a passion for forward-thinking discoveries. We want to develop products and solutions for a better life. That's why we take a closer look at things, ask questions and think ahead.
More than 52,000 employees in 66 countries work together with us on innovative solutions and the newest technologies in healthcare, life science and performance materials. From improving electronic devices with smarter materials to generating ultra pure water, testing the quality of food and drugs, and treating cancer, Merck always promotes opportunities to break new ground.
